Spyre Therapeutics, Inc. - Common Stock SYRE 深 滬
交易中 09-20 15:20:45 美东时间
31.30
+0.900
+2.96%
華盛通- 最 高31.89
- 今 開30.24
- 成交量 55.33万股
- 最 低 30.04
- 昨 收 30.40
- 總市值 15.90亿
- 52周最高 47.97
- 市盈率 靜 --
- 換手率 1.09%
- 52周最低 8.43
- 委 比 -99.28%
- 總股本 5079.24万
- 歷史最高 318.75
- 量 比 1.12
- 振 幅 6.09%
- 歷史最低 2.66
- 每 手 1
- 風險率 9.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股周涨跌榜 | B站周涨逾20%！618期间订单量暴涨；特朗普媒体科技集团周跌逾25%
Sarepta周涨30.8%，儿童致命疾病基因疗法获FDA批准；哔哩哔哩周涨23.2%，618期间订单量暴涨154%；特朗普媒体科技集团周跌逾25%，SEC批准投资者将持有的认股权证转换成股票>>
06-22 16:16
Spyre Therapeutics Expands Portfolio and Strengthens Leadership
The latest update is out from Spyre Therapeutics (SYRE). Spyre Therapeutics, In...
05-15 19:52
Positive Outlook on Spyre Therapeutics’ IBD Pipeline and Financial Stability
Analyst Colleen M. Kusy from Robert W. Baird maintained a Buy rating on Spyre T...
05-14 16:48
Spyre Therapeutics GAAP EPS of -$1.20
Spyre Therapeutics press release (NASDAQ:SYRE): Q1 GAAP EPS of -$1.20. As of March 31, 2024, Spyre had available cash and cash equivalents, marketable securities, and restricted cash of $485M. More on...
05-10 06:00
22亿美元，3月Biotech融资规模重回加息前
转自：新康界 3月，美国及欧洲的生物医药行业共发生16起融资事件，融资规模达21.97亿美元，其中值得关注的有： 自免药物领域：自免药物仍是行业热点，3月规模...
04-22 16:18
美股周涨跌榜 | 英伟达“爱股”一周狂飙52%！微策略再升25%创历史新高
英伟达“爱股”Soundhound AI股价一周狂飙52%；“炒币巨头”微策略周内再涨超25%，股价创历史新高>>
03-17 12:32
美股周涨跌榜 | 微策略周涨32.1%，比特币一度突破7万美元再创新高；“AI宠儿”超微电脑周涨25.9%
加密货币概念股微策略周涨32.1%，比特币一度突破7万美元再创新高；“AI宠儿”超微电脑周涨25.9%，创历史新高；市场挑战或致Q1亏损，维多利亚的秘密周跌36.3%>>
03-09 15:04
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
03-05 23:56
Spyre Therapeutics Q4 EPS $(4.05) Up From $(5.00) YoY
Spyre Therapeutics (NASDAQ:SYRE) reported quarterly losses of $(4.05) per share. This is a 19 percent increase over losses of $(5.00) per share from the same period last year.
03-01 05:32
Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., Dec. 22, 2023 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre") (NASDAQ: SYRE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to t...
2023-12-23 06:00
